Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

A sensitive immunohistochemical method for phosphorylated α-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson’s disease (PD), 9 with d...

Full description

Saved in:
Bibliographic Details
Published inActa neuropathologica Vol. 119; no. 6; pp. 689 - 702
Main Authors Beach, Thomas G., Adler, Charles H., Sue, Lucia I., Vedders, Linda, Lue, LihFen, White III, Charles L., Akiyama, Haru, Caviness, John N., Shill, Holly A., Sabbagh, Marwan N., Walker, Douglas G.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.06.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A sensitive immunohistochemical method for phosphorylated α-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson’s disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer’s disease with Lewy bodies (ADLB) and 17 with Alzheimer’s disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated α-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.
AbstractList A sensitive immunohistochemical method for phosphorylated α-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson’s disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer’s disease with Lewy bodies (ADLB) and 17 with Alzheimer’s disease with no Lewy bodies (AD-NLB). The relative densities and frequencies of occurrence of phosphorylated α-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.
A sensitive immunohistochemical method for phosphorylated alpha-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson's disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer's disease with Lewy bodies (ADLB) and 17 with Alzheimer's disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated alpha-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.
A sensitive immunohistochemical method for phosphorylated α-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson’s disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer’s disease with Lewy bodies (ADLB) and 17 with Alzheimer’s disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated α-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.
A sensitive immunohistochemical method for phosphorylated alpha-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson's disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer's disease with Lewy bodies (ADLB) and 17 with Alzheimer's disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated alpha-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.A sensitive immunohistochemical method for phosphorylated alpha-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in the bodies of 92 subjects, including 23 normal elderly, 7 with incidental Lewy body disease (ILBD), 17 with Parkinson's disease (PD), 9 with dementia with Lewy bodies (DLB), 19 with Alzheimer's disease with Lewy bodies (ADLB) and 17 with Alzheimer's disease with no Lewy bodies (ADNLB). The relative densities and frequencies of occurrence of phosphorylated alpha-synuclein histopathology (PASH) were tabulated and correlated with diagnostic category. The greatest densities and frequencies of PASH occurred in the spinal cord, followed by the paraspinal sympathetic ganglia, the vagus nerve, the gastrointestinal tract and endocrine organs. The frequency of PASH within other organs and tissue types was much lower. Spinal cord and peripheral PASH was most common in subjects with PD and DLB, where it appears likely that it is universally widespread. Subjects with ILBD had lesser densities of PASH within all regions, but had frequent involvement of the spinal cord and paraspinal sympathetic ganglia, with less-frequent involvement of end-organs. Subjects with ADLB had infrequent involvement of the spinal cord and paraspinal sympathetic ganglia with rare involvement of end-organs. Within the gastrointestinal tract, there was a rostrocaudal gradient of decreasing PASH frequency and density, with the lower esophagus and submandibular gland having the greatest involvement and the colon and rectum the lowest.
Author Shill, Holly A.
Sue, Lucia I.
White III, Charles L.
Caviness, John N.
Vedders, Linda
Akiyama, Haru
Walker, Douglas G.
Beach, Thomas G.
Lue, LihFen
Sabbagh, Marwan N.
Adler, Charles H.
Author_xml – sequence: 1
  givenname: Thomas G.
  surname: Beach
  fullname: Beach, Thomas G.
  email: thomas.beach@bannerhealth.com
  organization: Sun Health Research Institute
– sequence: 2
  givenname: Charles H.
  surname: Adler
  fullname: Adler, Charles H.
  organization: Mayo Clinic
– sequence: 3
  givenname: Lucia I.
  surname: Sue
  fullname: Sue, Lucia I.
  organization: Sun Health Research Institute
– sequence: 4
  givenname: Linda
  surname: Vedders
  fullname: Vedders, Linda
  organization: Sun Health Research Institute
– sequence: 5
  givenname: LihFen
  surname: Lue
  fullname: Lue, LihFen
  organization: Sun Health Research Institute
– sequence: 6
  givenname: Charles L.
  surname: White III
  fullname: White III, Charles L.
  organization: University of Texas Southwestern Medical Center
– sequence: 7
  givenname: Haru
  surname: Akiyama
  fullname: Akiyama, Haru
  organization: Tokyo Institute of Psychiatry
– sequence: 8
  givenname: John N.
  surname: Caviness
  fullname: Caviness, John N.
  organization: Mayo Clinic
– sequence: 9
  givenname: Holly A.
  surname: Shill
  fullname: Shill, Holly A.
  organization: Sun Health Research Institute
– sequence: 10
  givenname: Marwan N.
  surname: Sabbagh
  fullname: Sabbagh, Marwan N.
  organization: Sun Health Research Institute
– sequence: 11
  givenname: Douglas G.
  surname: Walker
  fullname: Walker, Douglas G.
  organization: Sun Health Research Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20306269$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1uFDEQhS0URCaBA7BB3rFqKP-0e3qDhCIISIPYwNqy3e5pDx57sN2J-lhchDPFowkRsMjCslz1vldWvQt0FmKwCL0k8IYAdG8zAAfSAIEGhOANe4JWhDPaQMvYGVoB1K5glJ6ji5x39UU73j5D5xQYCCr6FfrxZfbFNTFtVcCDyyU5PRcXA44jPkwx15MWr4od8O9fTV7CbLx1AU9VGw-qTNHH7YJrJc96Z03J-NaVCW_s7YJ1HJaja0yDTfk5ejoqn-2L-_sSff_44dvVp2bz9frz1ftNY1i_Ls1oDddCgSZcjWRN9QCt5p0wRnctVT3T2hqqVd9r0_MRgGpOSD90FYRBaXaJ3p18D7Pe28HYUJLy8pDcXqVFRuXkv53gJrmNN5KuhYAeqsHre4MUf842F7l32VjvVbBxzrJjjENLOlKVr_4e9TDjz4KrgJwEJsWckx0fJATkMUR5ClHWEOUxRMkq0_3HGFfUMZT6W-cfJemJzHVK2Nokd3FOoS77EegOhZy1tA
CitedBy_id crossref_primary_10_1016_j_apsb_2021_03_020
crossref_primary_10_1155_2016_1720621
crossref_primary_10_1212_WNL_0b013e3182840782
crossref_primary_10_1016_j_nbd_2011_10_014
crossref_primary_10_1016_j_parkreldis_2012_06_008
crossref_primary_10_1586_14737175_2014_877842
crossref_primary_10_3233_JPD_212733
crossref_primary_10_1016_j_dld_2018_03_010
crossref_primary_10_1007_s00702_014_1355_3
crossref_primary_10_1016_j_nrleng_2020_08_023
crossref_primary_10_3390_ijms25147741
crossref_primary_10_1007_s13311_023_01379_z
crossref_primary_10_1111_j_1365_2982_2012_01974_x
crossref_primary_10_3389_fneur_2019_01328
crossref_primary_10_3390_ijms231911394
crossref_primary_10_1016_j_nbd_2011_10_019
crossref_primary_10_1152_ajpgi_00162_2023
crossref_primary_10_1002_mds_27186
crossref_primary_10_1007_s00415_018_8789_8
crossref_primary_10_1007_s12035_024_04435_7
crossref_primary_10_1016_j_lpm_2016_11_010
crossref_primary_10_1212_WNL_0000000000200110
crossref_primary_10_3389_fneur_2021_681413
crossref_primary_10_1038_s41531_023_00491_3
crossref_primary_10_1111_neup_12790
crossref_primary_10_1038_nrneurol_2014_88
crossref_primary_10_1002_ana_24430
crossref_primary_10_3389_fncel_2018_00479
crossref_primary_10_1016_j_artmed_2021_102061
crossref_primary_10_1016_j_nbd_2012_04_013
crossref_primary_10_1038_srep33117
crossref_primary_10_1017_cjn_2023_291
crossref_primary_10_1007_s00401_017_1777_8
crossref_primary_10_1212_WNL_0000000000004496
crossref_primary_10_1016_j_parkreldis_2020_08_020
crossref_primary_10_1155_2023_3555418
crossref_primary_10_1111_psyg_13147
crossref_primary_10_3389_fnagi_2022_907293
crossref_primary_10_1186_s40478_016_0305_8
crossref_primary_10_1002_med_22091
crossref_primary_10_1093_brain_awv164
crossref_primary_10_3892_etm_2023_12311
crossref_primary_10_1155_2020_4687530
crossref_primary_10_1124_pharmrev_120_000189
crossref_primary_10_1002_mds_29354
crossref_primary_10_1055_s_0042_1758780
crossref_primary_10_1136_jnnp_2011_301817
crossref_primary_10_1007_s00702_021_02445_6
crossref_primary_10_3390_cells8030222
crossref_primary_10_1155_2022_4108401
crossref_primary_10_1007_s00401_017_1788_5
crossref_primary_10_1002_agm2_12192
crossref_primary_10_1016_j_neuro_2018_06_002
crossref_primary_10_3233_JPD_171088
crossref_primary_10_3233_JPD_212876
crossref_primary_10_3389_fcell_2021_716300
crossref_primary_10_1007_s11064_022_03586_0
crossref_primary_10_1111_ncn3_12444
crossref_primary_10_1097_MD_0000000000011337
crossref_primary_10_3238_PersNeuro_2020_07_08_01
crossref_primary_10_1016_j_jddst_2021_102793
crossref_primary_10_1016_j_nbd_2014_08_026
crossref_primary_10_1016_j_parkreldis_2018_11_014
crossref_primary_10_1007_s00441_018_2851_9
crossref_primary_10_1038_s41531_016_0002_0
crossref_primary_10_1007_s00401_024_02781_3
crossref_primary_10_1016_j_jns_2011_09_030
crossref_primary_10_1093_sleep_zsad310
crossref_primary_10_1186_s42466_024_00354_z
crossref_primary_10_1007_s00415_023_11770_7
crossref_primary_10_1016_j_nbd_2012_04_009
crossref_primary_10_1016_j_parkreldis_2018_11_016
crossref_primary_10_3390_brainsci13040609
crossref_primary_10_1016_j_neurobiolaging_2022_02_010
crossref_primary_10_1186_s40478_018_0509_1
crossref_primary_10_4103_1673_5374_265792
crossref_primary_10_3390_jcm10030493
crossref_primary_10_1007_s12640_013_9420_5
crossref_primary_10_1016_j_neurol_2013_05_004
crossref_primary_10_1016_j_parkreldis_2021_11_023
crossref_primary_10_1111_neup_12772
crossref_primary_10_3389_fnins_2020_614331
crossref_primary_10_1002_mds_23838
crossref_primary_10_1007_s00401_019_02040_w
crossref_primary_10_1186_s13195_017_0242_1
crossref_primary_10_3389_fnagi_2022_1066331
crossref_primary_10_1016_j_parkreldis_2015_12_008
crossref_primary_10_3390_pharmaceutics15030770
crossref_primary_10_31083_j_fbl2802033
crossref_primary_10_1212_WNL_0b013e31824bd195
crossref_primary_10_1002_mds_24921
crossref_primary_10_1007_s00401_010_0706_x
crossref_primary_10_1080_14737175_2020_1701437
crossref_primary_10_1007_s00441_018_2863_5
crossref_primary_10_1016_j_parkreldis_2020_07_004
crossref_primary_10_26599_BSA_2019_9050009
crossref_primary_10_1016_j_autneu_2025_103258
crossref_primary_10_1186_s40478_022_01487_5
crossref_primary_10_17116_jnevro202212208121
crossref_primary_10_1002_ana_24448
crossref_primary_10_1007_s10286_019_00620_0
crossref_primary_10_1038_s41531_017_0017_1
crossref_primary_10_1212_WNL_0b013e318236ef60
crossref_primary_10_1111_j_1365_2982_2012_01887_x
crossref_primary_10_1093_brain_awae069
crossref_primary_10_3390_ijms21228666
crossref_primary_10_33549_physiolres_934405
crossref_primary_10_1016_j_neurol_2015_10_005
crossref_primary_10_1212_WNL_0b013e31827deb74
crossref_primary_10_1586_ern_12_17
crossref_primary_10_1080_17460441_2019_1638908
crossref_primary_10_1111_nmo_14354
crossref_primary_10_3389_fneur_2023_1149604
crossref_primary_10_1001_jamaneurol_2020_3311
crossref_primary_10_3389_fnins_2021_731602
crossref_primary_10_1007_s12035_021_02596_3
crossref_primary_10_3390_cells10030656
crossref_primary_10_1007_s00455_024_10693_3
crossref_primary_10_1016_j_neulet_2023_137330
crossref_primary_10_1016_j_neuroscience_2019_05_029
crossref_primary_10_1007_s40141_023_00393_8
crossref_primary_10_1007_s00441_018_2832_z
crossref_primary_10_1093_brain_awv251
crossref_primary_10_1111_jnc_12742
crossref_primary_10_1586_14737175_2015_1083423
crossref_primary_10_1016_j_jacc_2018_05_079
crossref_primary_10_1038_nrn3887
crossref_primary_10_1093_brain_awv138
crossref_primary_10_25692_ACEN_2020_1_7
crossref_primary_10_1038_s41598_023_41662_9
crossref_primary_10_1007_s00401_015_1485_1
crossref_primary_10_3389_fncel_2016_00073
crossref_primary_10_1111_ene_12753
crossref_primary_10_1016_j_nrleng_2018_12_017
crossref_primary_10_1093_jnen_nlw103
crossref_primary_10_3233_JAD_220275
crossref_primary_10_3389_fnagi_2022_909273
crossref_primary_10_1007_s00401_022_02426_3
crossref_primary_10_3233_JPD_230256
crossref_primary_10_1038_s41531_023_00511_2
crossref_primary_10_1002_gps_4742
crossref_primary_10_1016_j_drugalcdep_2021_108746
crossref_primary_10_1016_j_nbd_2011_08_014
crossref_primary_10_1016_j_praneu_2016_01_021
crossref_primary_10_1186_s40478_025_01956_7
crossref_primary_10_1016_j_parkreldis_2010_11_005
crossref_primary_10_1016_j_parkreldis_2014_10_010
crossref_primary_10_1111_jnc_13845
crossref_primary_10_1002_ana_24500
crossref_primary_10_1007_s00415_011_6061_6
crossref_primary_10_1007_s11910_015_0549_x
crossref_primary_10_1186_s40478_018_0541_1
crossref_primary_10_1016_S1474_4422_13_70054_1
crossref_primary_10_1128_JVI_01399_16
crossref_primary_10_1586_ern_11_163
crossref_primary_10_1016_j_neurol_2023_11_004
crossref_primary_10_1007_s11910_018_0889_4
crossref_primary_10_1002_mds_25708
crossref_primary_10_1002_mds_30028
crossref_primary_10_1155_2018_4784268
crossref_primary_10_1109_JSEN_2023_3239887
crossref_primary_10_1212_WNL_0000000000012060
crossref_primary_10_3389_fneur_2018_00525
crossref_primary_10_3390_antiox11010141
crossref_primary_10_3233_JPD_191610
crossref_primary_10_1007_s11481_012_9402_z
crossref_primary_10_3988_jcn_2019_15_2_135
crossref_primary_10_1042_BST20180466
crossref_primary_10_15252_emmm_201505439
crossref_primary_10_1007_s12350_019_01977_5
crossref_primary_10_1016_j_molmed_2018_09_004
crossref_primary_10_1111_nmo_12070
crossref_primary_10_17116_jnevro202212211219
crossref_primary_10_3390_ijms21061961
crossref_primary_10_1186_alzrt274
crossref_primary_10_1212_WNL_0000000000007941
crossref_primary_10_1186_s40478_021_01175_w
crossref_primary_10_1016_j_revmed_2012_01_004
crossref_primary_10_1016_j_praneu_2013_10_009
crossref_primary_10_3233_ADR_240110
crossref_primary_10_1111_ncn3_12596
crossref_primary_10_1002_alz_12880
crossref_primary_10_1007_s00401_019_02071_3
crossref_primary_10_1038_nrneurol_2016_196
crossref_primary_10_3233_JPD_212707
crossref_primary_10_1371_journal_pone_0154544
crossref_primary_10_1002_ana_24648
crossref_primary_10_1186_s40478_015_0196_0
crossref_primary_10_1371_journal_pone_0102909
crossref_primary_10_3233_JPD_191729
crossref_primary_10_1016_j_neuroscience_2014_02_002
crossref_primary_10_3233_JPD_240007
crossref_primary_10_1186_s13024_021_00501_z
crossref_primary_10_1002_mds_27907
crossref_primary_10_1016_j_bbamcr_2022_119243
crossref_primary_10_1089_ars_2014_5859
crossref_primary_10_1002_mds_25844
crossref_primary_10_1097_NEN_0000000000000235
crossref_primary_10_3390_v13050759
crossref_primary_10_1002_mds_23305
crossref_primary_10_1002_mds_25966
crossref_primary_10_1007_s11910_015_0607_4
crossref_primary_10_1016_j_brainresrev_2010_05_006
crossref_primary_10_1212_WNL_0000000000002126
crossref_primary_10_5056_jnm19044
crossref_primary_10_3389_fcell_2020_573696
crossref_primary_10_3390_ijms19061689
crossref_primary_10_14336_AD_2021_0418
crossref_primary_10_3233_JPD_240019
crossref_primary_10_1007_s10286_013_0217_7
crossref_primary_10_1007_s11910_014_0495_z
crossref_primary_10_4303_ne_235955
crossref_primary_10_1136_jnnp_2020_322815
crossref_primary_10_1038_s41531_024_00766_3
crossref_primary_10_3390_cells9040841
crossref_primary_10_1186_s12916_020_01873_7
crossref_primary_10_3389_fneur_2021_805135
crossref_primary_10_1186_s40035_023_00370_0
crossref_primary_10_1111_j_1365_2982_2011_01794_x
crossref_primary_10_1093_brain_awy157
crossref_primary_10_1007_s00401_019_01977_2
crossref_primary_10_1097_PAI_0000000000000613
crossref_primary_10_3390_biom12040576
crossref_primary_10_1002_mdc3_14031
crossref_primary_10_1007_s00401_014_1268_0
crossref_primary_10_1007_s00415_012_6801_2
crossref_primary_10_1038_srep02540
crossref_primary_10_1016_j_nbd_2014_05_009
crossref_primary_10_1016_j_expneurol_2018_10_014
crossref_primary_10_1007_s12035_012_8267_8
crossref_primary_10_1111_nmo_14604
crossref_primary_10_1016_j_lpm_2011_11_018
crossref_primary_10_1007_s40141_023_00392_9
crossref_primary_10_1111_nmo_12797
crossref_primary_10_1002_mds_25502
crossref_primary_10_3233_JAD_240198
crossref_primary_10_1007_s00415_019_09321_0
crossref_primary_10_37349_ent_2023_00049
crossref_primary_10_3389_fnins_2019_00839
crossref_primary_10_1212_WNL_0000000000002102
crossref_primary_10_1097_NEN_0000000000000137
crossref_primary_10_1186_s40035_022_00289_y
crossref_primary_10_3389_fnins_2020_580311
crossref_primary_10_1212_WNL_0000000000001240
crossref_primary_10_1016_j_neulet_2024_137702
crossref_primary_10_3390_jcm10235698
crossref_primary_10_1002_mds_23795
crossref_primary_10_3233_JPD_230315
crossref_primary_10_1002_mds_26702
crossref_primary_10_1002_mds_23677
crossref_primary_10_1002_mds_25736
crossref_primary_10_1038_s41531_024_00842_8
crossref_primary_10_3389_fnins_2019_00728
crossref_primary_10_1002_mds_25979
crossref_primary_10_1136_jclinpath_2019_205952
crossref_primary_10_1186_s40035_017_0074_8
crossref_primary_10_1007_s00702_017_1720_0
crossref_primary_10_1186_s13024_019_0306_8
crossref_primary_10_1038_s41467_021_26066_5
crossref_primary_10_1016_S1474_4422_23_00109_6
crossref_primary_10_3390_ijms18122633
crossref_primary_10_1097_WCO_0000000000000948
crossref_primary_10_1101_cshperspect_a023630
crossref_primary_10_1136_gutjnl_2021_326023
crossref_primary_10_1111_bpa_12560
crossref_primary_10_1016_j_parkreldis_2017_05_001
crossref_primary_10_1186_s40478_015_0236_9
crossref_primary_10_1002_acn3_285
crossref_primary_10_1111_ene_15069
crossref_primary_10_1016_j_banm_2019_11_013
crossref_primary_10_3389_fimmu_2019_00303
crossref_primary_10_1002_mds_26605
crossref_primary_10_1097_NEN_0b013e3182965886
crossref_primary_10_1002_nep3_60
crossref_primary_10_1007_s40120_024_00620_x
crossref_primary_10_1016_j_nrl_2020_08_020
crossref_primary_10_1093_brain_awaa008
crossref_primary_10_1002_ana_24901
crossref_primary_10_1038_s41380_021_01296_7
crossref_primary_10_1016_j_parkreldis_2012_07_005
crossref_primary_10_1016_j_jns_2015_02_033
crossref_primary_10_1177_2096595820902566
crossref_primary_10_1016_j_pathol_2024_10_006
crossref_primary_10_1186_s40035_023_00392_8
crossref_primary_10_3390_biom13040644
crossref_primary_10_1007_s12149_022_01728_6
crossref_primary_10_1016_j_trac_2023_117150
crossref_primary_10_1016_j_sleep_2018_08_003
crossref_primary_10_1111_jns5_12056
crossref_primary_10_1007_s00401_018_1832_0
crossref_primary_10_3390_ijms241914925
crossref_primary_10_1523_ENEURO_0216_16_2017
crossref_primary_10_1111_pin_13389
crossref_primary_10_1002_mds_25789
crossref_primary_10_1212_WNL_0000000000003633
crossref_primary_10_2174_0929867325666180226094351
crossref_primary_10_1007_s00401_020_02233_8
crossref_primary_10_3390_brainsci6020017
crossref_primary_10_1038_nrn_2017_75
crossref_primary_10_17116_jnevro2016116111174_179
crossref_primary_10_1007_s00259_019_04480_8
crossref_primary_10_1016_j_expneurol_2020_113284
crossref_primary_10_1016_j_parkreldis_2018_08_010
crossref_primary_10_1007_s00401_012_1040_2
crossref_primary_10_1016_j_jns_2015_01_012
crossref_primary_10_3389_fnins_2020_00626
crossref_primary_10_1016_j_parkreldis_2021_04_030
crossref_primary_10_1002_mds_25776
crossref_primary_10_1002_mds_26866
crossref_primary_10_1002_mds_25779
crossref_primary_10_1007_s10286_018_00584_7
crossref_primary_10_3390_biomedicines9030272
crossref_primary_10_1186_s12916_015_0310_y
crossref_primary_10_1002_mds_25895
crossref_primary_10_18231_j_ijnmhs_2020_015
crossref_primary_10_1016_j_neulet_2019_03_054
crossref_primary_10_3389_fnagi_2018_00237
crossref_primary_10_1093_brain_awr015
crossref_primary_10_1097_NEN_0b013e3182805c72
crossref_primary_10_1186_2051_5960_1_2
crossref_primary_10_1002_mdc3_12395
crossref_primary_10_5056_jnm17141
crossref_primary_10_3389_fnins_2016_00269
crossref_primary_10_1177_00220345211004842
crossref_primary_10_1002_gps_5100
crossref_primary_10_1038_s41467_024_49402_x
crossref_primary_10_1042_NS20210026
crossref_primary_10_3233_JPD_160888
crossref_primary_10_1152_jn_00548_2020
crossref_primary_10_3390_antiox10050715
crossref_primary_10_1002_mds_25445
crossref_primary_10_1111_febs_15721
crossref_primary_10_1016_j_isci_2021_102863
crossref_primary_10_1186_s12974_023_02720_1
crossref_primary_10_3233_JPD_202489
crossref_primary_10_3389_fnsyn_2020_584536
crossref_primary_10_3389_fphys_2021_626640
crossref_primary_10_3233_JPD_223180
crossref_primary_10_1016_j_parkreldis_2019_01_024
crossref_primary_10_1186_s10020_021_00279_2
crossref_primary_10_3233_JPD_202481
crossref_primary_10_1093_brain_awac115
crossref_primary_10_1093_braincomms_fcab113
crossref_primary_10_1002_mdc3_70029
crossref_primary_10_3233_JPD_181477
crossref_primary_10_1021_acschemneuro_4c00459
crossref_primary_10_1007_s13311_022_01288_7
crossref_primary_10_1080_07853890_2021_1890330
crossref_primary_10_1016_j_autneu_2021_102858
crossref_primary_10_1016_S1474_4422_15_00007_1
crossref_primary_10_1097_NEN_0b013e318258381b
crossref_primary_10_1111_jnc_14330
crossref_primary_10_3233_JPD_225111
crossref_primary_10_3233_JPD_223294
crossref_primary_10_1007_s00702_019_02028_6
crossref_primary_10_2478_s13380_012_0013_1
crossref_primary_10_1002_mds_26529
crossref_primary_10_1016_j_neuroscience_2022_09_019
crossref_primary_10_1212_WNL_0000000000003961
crossref_primary_10_1007_s12223_022_00977_2
crossref_primary_10_1111_ane_12247
crossref_primary_10_1007_s00115_012_3575_9
crossref_primary_10_1016_j_nbd_2012_07_018
crossref_primary_10_1016_j_parkreldis_2016_10_011
crossref_primary_10_1016_j_nrl_2018_12_008
crossref_primary_10_1016_j_neurol_2022_12_010
crossref_primary_10_1016_j_praneu_2018_02_007
crossref_primary_10_1016_j_parkreldis_2022_08_012
crossref_primary_10_1371_journal_pone_0253216
crossref_primary_10_1080_10408363_2019_1711359
crossref_primary_10_3390_ijms19124129
crossref_primary_10_14802_jmd_16061
crossref_primary_10_3389_fnagi_2021_703984
crossref_primary_10_1002_mds_25467
crossref_primary_10_1016_j_ibneur_2025_02_009
crossref_primary_10_3389_fendo_2014_00142
crossref_primary_10_3389_fneur_2022_852003
crossref_primary_10_1093_braincomms_fcaa004
crossref_primary_10_1369_0022155420960250
crossref_primary_10_1016_j_nbd_2022_105806
crossref_primary_10_1007_s10286_019_00595_y
crossref_primary_10_17816_ACEN_1129
crossref_primary_10_3389_fimmu_2021_676621
crossref_primary_10_1016_j_jns_2011_04_012
crossref_primary_10_1007_s11910_015_0599_0
crossref_primary_10_1212_WNL_0000000000000204
crossref_primary_10_1084_jem_20112457
crossref_primary_10_1007_s00401_010_0789_4
crossref_primary_10_1016_j_jocn_2019_05_033
crossref_primary_10_3389_fneur_2024_1407241
crossref_primary_10_1016_S1474_4422_21_00176_9
crossref_primary_10_1051_medsci_2024082
crossref_primary_10_1016_j_parkreldis_2016_10_024
crossref_primary_10_3892_mmr_2016_5166
crossref_primary_10_1016_j_expneurol_2012_11_020
crossref_primary_10_1016_j_nbd_2019_05_002
crossref_primary_10_1016_j_neulet_2014_04_027
crossref_primary_10_3390_jcm9113705
crossref_primary_10_1111_jnc_15320
crossref_primary_10_1212_WNL_0000000000000316
crossref_primary_10_3390_cells10020375
crossref_primary_10_3390_ijms23179739
crossref_primary_10_3233_JPD_150736
crossref_primary_10_1016_j_ijpharm_2017_08_126
crossref_primary_10_7759_cureus_38907
crossref_primary_10_1007_s00702_018_1898_9
crossref_primary_10_1111_nan_12299
crossref_primary_10_1111_nan_12298
crossref_primary_10_3390_ijms222111594
crossref_primary_10_1016_j_parkreldis_2021_05_022
crossref_primary_10_1038_nrneurol_2015_197
crossref_primary_10_1002_acn3_78
crossref_primary_10_1111_neup_12189
crossref_primary_10_14802_jmd_18067
crossref_primary_10_3109_00207454_2011_620192
crossref_primary_10_1080_10790268_2018_1557863
crossref_primary_10_1007_s00415_022_11461_9
crossref_primary_10_1126_scitranslmed_aar5280
crossref_primary_10_1186_s40035_019_0146_z
crossref_primary_10_1016_j_neurobiolaging_2013_08_008
crossref_primary_10_1002_mdc3_13319
crossref_primary_10_1002_mds_28636
crossref_primary_10_1016_S0001_4079_19_31683_8
crossref_primary_10_1038_s41540_020_00156_4
crossref_primary_10_1002_mdc3_13312
crossref_primary_10_1016_j_praneu_2014_01_011
crossref_primary_10_3390_brainsci13121681
crossref_primary_10_1080_00207454_2018_1466781
crossref_primary_10_3389_fcimb_2023_1181315
crossref_primary_10_5056_jnm17105
crossref_primary_10_1016_j_parkreldis_2020_11_017
crossref_primary_10_1093_brain_awab061
crossref_primary_10_1016_j_neulet_2017_01_050
crossref_primary_10_1016_j_tins_2016_10_008
crossref_primary_10_1093_brain_awaa096
crossref_primary_10_1136_jmedgenet_2019_106210
crossref_primary_10_1016_j_neulet_2013_08_019
crossref_primary_10_1111_ejn_15324
crossref_primary_10_3390_biology12020195
crossref_primary_10_3390_cells10020283
crossref_primary_10_1016_j_pneurobio_2024_102673
crossref_primary_10_3389_fneur_2024_1367974
crossref_primary_10_1155_2015_156479
crossref_primary_10_1016_j_neurobiolaging_2013_08_012
crossref_primary_10_3233_JPD_202459
crossref_primary_10_1002_mds_28986
crossref_primary_10_1016_j_nbd_2012_06_005
crossref_primary_10_3109_00207454_2011_613551
crossref_primary_10_1093_braincomms_fcab045
crossref_primary_10_18632_aging_204266
crossref_primary_10_1517_14656566_2015_997211
crossref_primary_10_1038_s41531_022_00295_x
crossref_primary_10_2174_0929867325666181009161048
crossref_primary_10_1002_mds_26480
crossref_primary_10_1007_s10286_018_0581_4
crossref_primary_10_1016_j_neurol_2016_07_001
crossref_primary_10_3233_JPD_223161
crossref_primary_10_1002_mds_25020
crossref_primary_10_1002_mds_29620
crossref_primary_10_1093_jnen_nlz080
crossref_primary_10_1007_s40473_017_0129_2
crossref_primary_10_1212_WNL_0000000000000641
crossref_primary_10_1002_mds_26473
crossref_primary_10_1002_mds_26476
crossref_primary_10_3233_JPD_202341
crossref_primary_10_1016_j_nbd_2021_105601
crossref_primary_10_1016_j_neuron_2014_10_031
crossref_primary_10_1038_s41531_023_00582_1
crossref_primary_10_3390_ijms17020189
crossref_primary_10_1016_j_brainres_2019_146460
crossref_primary_10_1007_s00213_019_05265_5
crossref_primary_10_1007_s00415_022_11496_y
crossref_primary_10_1111_nmo_14822
crossref_primary_10_17343_sdutfd_1360587
crossref_primary_10_1002_mds_26347
crossref_primary_10_1111_bpa_12370
crossref_primary_10_1038_s41591_023_02358_9
crossref_primary_10_1016_j_ejphar_2017_05_042
crossref_primary_10_1038_s41593_025_01910_9
crossref_primary_10_1007_s12264_023_01123_9
crossref_primary_10_1002_mds_27794
crossref_primary_10_1007_s00401_024_02734_w
crossref_primary_10_1002_mds_27670
crossref_primary_10_1016_j_ensci_2022_100400
crossref_primary_10_1002_mds_26462
crossref_primary_10_3233_JPD_150773
crossref_primary_10_1007_s10522_013_9489_5
crossref_primary_10_1586_14737175_2015_1095093
crossref_primary_10_1002_mds_27556
crossref_primary_10_1016_j_pneurobio_2018_06_010
crossref_primary_10_1155_2016_9832839
crossref_primary_10_1016_j_nbd_2021_105599
crossref_primary_10_1186_s13024_023_00676_7
crossref_primary_10_1002_acn3_51347
crossref_primary_10_1007_s00216_023_04520_1
crossref_primary_10_3233_JPD_150680
crossref_primary_10_3389_fnagi_2020_575481
crossref_primary_10_3389_fnagi_2022_977572
crossref_primary_10_1111_neup_12269
crossref_primary_10_1007_s00401_016_1661_y
crossref_primary_10_18231_j_ijn_2024_042
crossref_primary_10_1016_j_nbd_2012_09_007
crossref_primary_10_1007_s13311_013_0234_1
crossref_primary_10_1007_s13311_020_00897_4
crossref_primary_10_1212_WNL_0000000000010428
crossref_primary_10_3389_fmed_2021_655123
crossref_primary_10_3748_wjg_v21_i37_10609
crossref_primary_10_1007_s41470_017_0004_1
crossref_primary_10_1093_jnen_nly056
crossref_primary_10_1016_j_parkreldis_2016_01_026
crossref_primary_10_1007_s00415_016_8348_0
crossref_primary_10_1016_j_prdoa_2024_100287
crossref_primary_10_3389_fnins_2020_00398
crossref_primary_10_1007_s00441_018_2856_4
crossref_primary_10_1002_mds_27343
crossref_primary_10_1002_mdc3_12425
crossref_primary_10_1002_mds_27105
crossref_primary_10_1016_j_stemcr_2015_11_004
crossref_primary_10_1002_mds_27344
crossref_primary_10_1021_acs_jpcb_2c08326
crossref_primary_10_1093_brain_awu369
crossref_primary_10_1016_S0140_6736_14_61393_3
crossref_primary_10_1212_WNL_0000000000006157
crossref_primary_10_3233_JPD_150670
crossref_primary_10_1016_j_nbd_2022_105883
crossref_primary_10_1515_hsz_2019_0142
crossref_primary_10_1038_s41531_022_00357_0
crossref_primary_10_1002_mdc3_13407
crossref_primary_10_31146_1682_8658_ecg_214_6_100_104
crossref_primary_10_1093_jnen_nlae015
crossref_primary_10_1016_j_parkreldis_2018_04_019
crossref_primary_10_1212_WNL_0b013e3182a9f449
crossref_primary_10_1016_j_smrv_2020_101283
crossref_primary_10_1111_jnc_15704
crossref_primary_10_1111_nan_12554
crossref_primary_10_1016_j_neulet_2013_07_016
crossref_primary_10_1007_s00455_023_10567_0
crossref_primary_10_1038_s41583_021_00542_9
crossref_primary_10_1016_j_parkreldis_2017_09_001
crossref_primary_10_1016_j_parkreldis_2020_05_001
crossref_primary_10_1093_brain_awad391
crossref_primary_10_1515_med_2021_0364
crossref_primary_10_2217_nmt_15_51
crossref_primary_10_1186_s13024_025_00804_5
crossref_primary_10_3389_fneur_2015_00256
crossref_primary_10_3389_fphar_2024_1468850
crossref_primary_10_3748_wjg_v22_i25_5742
crossref_primary_10_1016_j_parkreldis_2012_04_020
crossref_primary_10_1212_WNL_0000000000010404
crossref_primary_10_1007_s00401_012_1028_y
crossref_primary_10_1002_mds_27485
crossref_primary_10_1136_jnnp_2015_311680
crossref_primary_10_1021_acschemneuro_8b00383
crossref_primary_10_1212_WNL_0000000000000960
crossref_primary_10_1002_mds_25067
crossref_primary_10_1007_s00401_011_0852_9
crossref_primary_10_1016_j_neulet_2015_07_005
crossref_primary_10_1038_s41531_021_00262_y
crossref_primary_10_1093_brain_awad265
crossref_primary_10_1007_s00702_015_1405_5
crossref_primary_10_1016_j_jns_2024_122932
crossref_primary_10_3390_cells13151265
crossref_primary_10_4061_2011_708404
crossref_primary_10_3390_brainsci9070168
crossref_primary_10_1186_s40035_024_00407_y
crossref_primary_10_1016_j_nbd_2018_01_008
crossref_primary_10_1371_journal_pone_0104850
crossref_primary_10_3233_JPD_171131
crossref_primary_10_1080_14737175_2017_1392239
crossref_primary_10_1155_2015_476041
crossref_primary_10_1515_dmpt_2021_0144
crossref_primary_10_1016_j_nbd_2010_10_022
crossref_primary_10_3390_ijms21239199
crossref_primary_10_1016_j_ijbiomac_2022_01_115
crossref_primary_10_1186_s41983_020_0159_7
crossref_primary_10_1002_mds_27115
crossref_primary_10_1002_mds_25298
crossref_primary_10_1016_j_actbio_2021_03_071
crossref_primary_10_1155_2016_6762528
crossref_primary_10_1007_s00441_017_2733_6
crossref_primary_10_3390_ijms19113573
crossref_primary_10_3390_ijms23158376
crossref_primary_10_1016_j_nbd_2021_105557
crossref_primary_10_1007_s00702_023_02633_6
crossref_primary_10_14802_jmd_22042
crossref_primary_10_1002_mds_27392
crossref_primary_10_1007_s00702_017_1692_0
crossref_primary_10_1038_nrgastro_2013_18
crossref_primary_10_1111_nyas_13150
crossref_primary_10_3390_medsci4010001
crossref_primary_10_4103_AOMD_AOMD_4_18
crossref_primary_10_1016_j_lfs_2020_118976
crossref_primary_10_1007_s00702_010_0508_2
crossref_primary_10_1007_s00401_013_1214_6
crossref_primary_10_1126_sciadv_abn0356
crossref_primary_10_3233_JPD_171189
crossref_primary_10_3389_fnmol_2023_1197853
crossref_primary_10_4103_aian_aian_1001_22
crossref_primary_10_1097_NEN_0b013e318232a379
crossref_primary_10_1016_S1353_8020_13_70016_6
crossref_primary_10_3390_app10051828
crossref_primary_10_1016_j_parkreldis_2015_07_021
crossref_primary_10_1016_j_neulet_2021_135964
crossref_primary_10_1007_s42451_021_00352_4
crossref_primary_10_1101_cshperspect_a041618
crossref_primary_10_1016_j_neurobiolaging_2018_01_021
crossref_primary_10_1016_S1474_4422_16_00080_6
crossref_primary_10_1016_j_jneumeth_2013_03_010
crossref_primary_10_1093_hmg_ddz126
crossref_primary_10_1016_j_prp_2023_155023
crossref_primary_10_1016_j_expneurol_2012_12_008
crossref_primary_10_1016_j_neurol_2020_07_016
crossref_primary_10_3233_JPD_171071
crossref_primary_10_1007_s10072_022_06316_0
crossref_primary_10_2174_0118715273289138240306050532
crossref_primary_10_3390_ijms22158338
crossref_primary_10_1007_s12035_012_8280_y
crossref_primary_10_1136_jnnp_2015_311890
crossref_primary_10_1111_jnc_14656
crossref_primary_10_1111_jnc_14779
crossref_primary_10_1002_mds_27138
crossref_primary_10_1007_s00702_015_1459_4
crossref_primary_10_1016_j_neulet_2018_12_031
crossref_primary_10_1212_WNL_0000000000004163
crossref_primary_10_2174_1381612826666200212114038
crossref_primary_10_31083_j_jin2004108
crossref_primary_10_1016_j_parkreldis_2017_02_019
crossref_primary_10_1038_s41598_021_86917_5
crossref_primary_10_1016_j_neurol_2010_08_002
crossref_primary_10_1007_s11910_016_0655_4
crossref_primary_10_1016_j_neurobiolaging_2013_10_073
crossref_primary_10_1126_scitranslmed_aay1809
crossref_primary_10_3390_v13071394
crossref_primary_10_2174_1871527320666211206122407
crossref_primary_10_3390_biomedicines10092057
crossref_primary_10_1111_jnc_13570
crossref_primary_10_3390_microorganisms10081544
crossref_primary_10_1093_jnen_nlac023
crossref_primary_10_1212_WNL_0000000000011929
crossref_primary_10_3389_fneur_2017_00037
crossref_primary_10_1186_s40478_018_0568_3
crossref_primary_10_1136_jnnp_2020_324743
crossref_primary_10_1111_neup_12691
crossref_primary_10_1016_j_parkreldis_2017_02_026
crossref_primary_10_1016_j_parkreldis_2010_08_022
crossref_primary_10_1038_s41582_022_00681_2
crossref_primary_10_1113_EP092261
crossref_primary_10_1002_mds_28493
crossref_primary_10_1002_mds_29340
crossref_primary_10_1016_j_nbd_2022_105625
crossref_primary_10_3390_ijms22063038
crossref_primary_10_1038_nrneurol_2017_157
crossref_primary_10_1016_j_nbd_2018_09_015
crossref_primary_10_1016_j_preteyeres_2020_100938
crossref_primary_10_1111_nmo_12915
crossref_primary_10_1016_j_parkreldis_2018_10_028
crossref_primary_10_1007_s12350_019_01887_6
crossref_primary_10_1016_j_tem_2021_11_005
crossref_primary_10_1002_mdc3_12616
crossref_primary_10_1007_s00455_015_9612_7
crossref_primary_10_1038_s41575_020_0339_z
crossref_primary_10_1111_jnc_12131
crossref_primary_10_3390_ijms24087205
crossref_primary_10_1097_NEN_0b013e3182801cde
crossref_primary_10_3389_fnins_2021_821654
crossref_primary_10_3390_ijms25115988
crossref_primary_10_1007_s11894_018_0609_x
crossref_primary_10_1186_s40035_022_00311_3
crossref_primary_10_2217_bmm_2016_0366
crossref_primary_10_1097_WCO_0000000000000112
crossref_primary_10_3390_ijms21207471
crossref_primary_10_3389_fneur_2018_00376
crossref_primary_10_1002_mds_28004
crossref_primary_10_3390_biom12020168
Cites_doi 10.1007/BF00308809
10.1002/1531-8257(200003)15:2<238::AID-MDS1006>3.0.CO;2-J
10.1212/01.wnl.0000204179.88955.fa
10.1007/s00401-002-0651-4
10.1001/archneur.1973.00490280086013
10.1212/WNL.57.3.456
10.1007/s00401-008-0346-6
10.1016/j.neulet.2005.11.012
10.1007/s00401-009-0527-y
10.1002/mds.21065
10.1016/S1353-8020(01)00052-9
10.1093/cercor/4.2.138
10.1111/j.1365-2990.2007.00874.x
10.1007/BF02278018
10.1002/mds.20784
10.1016/S1474-4422(03)00307-7
10.1136/jnnp.23.4.283
10.1212/01.wnl.0000306697.48738.b6
10.1212/WNL.37.7.1253
10.1212/01.wnl.0000266593.50534.e8
10.1016/S1353-8020(02)00012-3
10.1038/nm1747
10.1006/exnr.2001.7805
10.1007/s004150070091
10.1007/BF00294234
10.1002/mds.22369
10.1093/jnen/63.7.742
10.1016/S1353-8020(01)00007-4
10.1212/WNL.47.5.1113
10.1007/s00441-004-0956-9
10.1097/nen.0b013e3180517454
10.1111/j.1471-4159.2009.06324.x
10.1212/WNL.23.9.990
10.1007/PL00009512
10.3109/00016359209012744
10.1002/mds.21560
10.1016/S0016-5085(84)80120-1
10.1212/WNL.52.6.1269
10.1007/s00702-004-0138-7
10.1136/jnnp.2007.133314
10.1007/s00401-008-0409-8
10.1111/j.1750-3639.1991.tb00661.x
10.1097/NEN.0b013e318186de48
10.1038/npp.2008.161
10.1007/BF00369454
10.1016/0016-5085(84)90079-9
10.1038/ncb841
10.1093/jnen/62.6.644
10.1212/01.wnl.0000312279.49272.9f
10.1007/s00401-008-0383-1
10.1001/archneur.56.1.33
10.1007/s004010050705
10.1093/jnen/61.5.413
10.1007/s00401-009-0538-8
10.1007/s00401-008-0450-7
10.1097/01.jnen.0000225908.90052.07
10.1007/s10561-008-9067-2
10.1212/WNL.41.4.479
10.1016/S0304-3940(98)00856-8
10.1212/01.WNL.0000138500.73671.DC
10.1111/j.1365-2990.2006.00727.x
10.1212/01.wnl.0000187889.17253.b1
10.1002/ana.20834
10.1007/s00401-007-0193-x
10.1002/mds.20189
10.1002/mds.22775
10.1002/mds.20460
10.1212/01.wnl.0000264429.59379.d9
10.1159/000113470
10.1016/0022-510X(73)90135-4
10.1007/BF00687767
10.1073/pnas.0903691106
10.1007/s00702-002-0808-2
10.1038/nm1746
10.1002/ana.10279
10.1523/JNEUROSCI.2617-07.2007
10.1016/S0079-6123(08)61859-2
ContentType Journal Article
Contributor Connor, Donald
Driver-Dunckley, Erika
Evidente, Virgilio
Contributor_xml – sequence: 1
  givenname: Erika
  surname: Driver-Dunckley
  fullname: Driver-Dunckley, Erika
– sequence: 2
  givenname: Virgilio
  surname: Evidente
  fullname: Evidente, Virgilio
– sequence: 3
  givenname: Donald
  surname: Connor
  fullname: Connor, Donald
Copyright Springer-Verlag 2010
Springer-Verlag 2010 2010
Copyright_xml – notice: Springer-Verlag 2010
– notice: Springer-Verlag 2010 2010
CorporateAuthor Arizona Parkinson’s Disease Consortium
Arizona Parkinson's Disease Consortium
CorporateAuthor_xml – name: Arizona Parkinson’s Disease Consortium
– name: Arizona Parkinson's Disease Consortium
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1007/s00401-010-0664-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-0533
EndPage 702
ExternalDocumentID PMC2866090
20306269
10_1007_s00401_010_0664_3
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIA NIH HHS
  grantid: P30 AG019610
– fundername: NIA NIH HHS
  grantid: P30 AG19610
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
23M
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABIVO
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFEXP
AFFNX
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DWQXO
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
INR
IPY
ITC
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAS
LLZTM
M1P
M2M
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK8
X7M
YLTOR
Z45
Z7U
Z7V
Z81
Z82
Z83
Z87
Z8O
Z8P
Z8U
Z8V
Z8W
Z91
ZGI
ZOVNA
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
PPXIY
5PM
ABRTQ
PJZUB
ID FETCH-LOGICAL-c398t-fec4b6a0b14af182bd05b476ccb752a93bbec2ba99bc94f002b4119d7fec0dab3
IEDL.DBID U2A
ISSN 0001-6322
1432-0533
IngestDate Thu Aug 21 18:00:21 EDT 2025
Fri Jul 11 10:31:43 EDT 2025
Sat May 31 02:11:53 EDT 2025
Thu Apr 24 22:50:20 EDT 2025
Tue Jul 01 03:38:05 EDT 2025
Fri Feb 21 02:35:55 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Peripheral nervous system
Heart
α-Synuclein
Stomach
Spinal cord
Alzheimer’s disease
Submandibular gland
Sympathetic nervous system
Esophagus
Parkinsonism
Enteric nervous system
Autonomic nervous system
Gastrointestinal system
Adrenal gland
Parkinson’s disease
Incidental Lewy bodies
Dementia with Lewy bodies
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c398t-fec4b6a0b14af182bd05b476ccb752a93bbec2ba99bc94f002b4119d7fec0dab3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 20306269
PQID 733405171
PQPubID 23479
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2866090
proquest_miscellaneous_733405171
pubmed_primary_20306269
crossref_primary_10_1007_s00401_010_0664_3
crossref_citationtrail_10_1007_s00401_010_0664_3
springer_journals_10_1007_s00401_010_0664_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-06-01
PublicationDateYYYYMMDD 2010-06-01
PublicationDate_xml – month: 06
  year: 2010
  text: 2010-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
PublicationTitle Acta neuropathologica
PublicationTitleAbbrev Acta Neuropathol
PublicationTitleAlternate Acta Neuropathol
PublicationYear 2010
Publisher Springer-Verlag
Publisher_xml – name: Springer-Verlag
References BatesonMCGibberdFBWilsonRSSalivary symptoms in Parkinson diseaseArch Neurol1973292742751:STN:280:DyaE3s3ks1Siug%3D%3D4728188
LiJYEnglundEHoltonJLSouletDHagellPLeesAJLashleyTQuinnNPRehncronaSBjorklundAWidnerHReveszTLindvallOBrundinPLewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagationNat Med20081450150310.1038/nm17461:CAS:528:DC%2BD1cXlsFCmsrs%3D18391963
SicaRESanzOPAn electrophysiological study of the functional changes in the spinal motoneurones in Parkinson’s diseaseElectromyogr Clin Neurophysiol1976164094171:STN:280:DyaE2s%2FptVyntA%3D%3D1009884
HawkesCHDel TrediciKBraakHParkinson’s disease: a dual-hit hypothesisNeuropathol Appl Neurobiol20073359961410.1111/j.1365-2990.2007.00874.x1:STN:280:DC%2BD2snmsF2ltA%3D%3D17961138
BeachTGAdlerCHLueLSueLIBachalakuriJHenry-WatsonJSasseJBoyerSShirohiSBrooksREschbacherJWhiteCLIIIAkiyamaHCavinessJShillHAConnorDJSabbaghMNWalkerDGUnified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathol200911761363410.1007/s00401-009-0538-819399512
BourasCHofPRGiannakopoulosPMichelJPMorrisonJHRegional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospitalCereb Cortex1994413815010.1093/cercor/4.2.1381:STN:280:DyaK2czht1ygsQ%3D%3D8038565
MikiYMoriFWakabayashiKKurodaNOrimoSIncidental Lewy body disease restricted to the heart and stellate gangliaMov Disord2009242299230110.1002/mds.2277519795472
TakedaSYamazakiKMiyakawaTAraiHParkinson’s disease with involvement of the parasympathetic gangliaActa Neuropathol19938639739810.1007/BF003694541:STN:280:DyaK2c%2FnvVOntQ%3D%3D8256591
UchikadoHLinWLDeLuciaMWDicksonDWAlzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathyJ Neuropathol Exp Neurol20066568569710.1097/01.jnen.0000225908.90052.071:CAS:528:DC%2BD28XotFeiu7c%3D16825955
O’SullivanSSHoltonJLMasseyLAWilliamsDRReveszTLeesAJParkinson’s disease with Onuf’s nucleus involvement mimicking multiple system atrophyJ Neurol Neurosurg Psychiatry20087923223410.1136/jnnp.2007.13331417951280
PerssonMOsterbergTGranerusAKKarlssonSInfluence of Parkinson’s disease on oral healthActa Odontol Scand199250374210.3109/000163592090127441:STN:280:DyaK383jtVCntg%3D%3D1348899
HladikCLWhiteCLComparison of digestive enzyme and formic acid pretreatment for optimal immunohistochemical demonstration of alpha-synuclein-immunoreactive cerebral cortical Lewy neuritesJ Neuropathol Exp Neurol200362554
PfeifferRFGastrointestinal dysfunction in Parkinson’s diseaseLancet Neurol2003210711610.1016/S1474-4422(03)00307-712849267
BeachTGWhiteCLHamiltonRLDudaJEIwatsuboTDicksonDWRoncaroliFButtiniMHladikCLSueLINoorigianJVAdlerCHEvaluation of alpha-synuclein immunohistochemical methods used by invited expertsActa Neuropathol200811627728810.1007/s00401-008-0409-81:CAS:528:DC%2BD1cXpsVGjsr4%3D18626651
DanzerKMKrebsSKWolffMBirkGHengererBSeeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathologyJ Neurochem200911119220310.1111/j.1471-4159.2009.06324.x1:CAS:528:DC%2BD1MXht1ertLbP19686384
SaitoYKawashimaARuberuNNFujiwaraHKoyamaSSawabeMAraiTNaguraHYamanouchiHHasegawaMIwatsuboTMurayamaSAccumulation of phosphorylated alpha-synuclein in aging human brainJ Neuropathol Exp Neurol2003626446541:CAS:528:DC%2BD3sXlt1yqu78%3D12834109
McKeithIGGalaskoDKosakaKPerryEKDicksonDWHansenLASalmonDPLoweJMirraSSByrneEJLennoxGQuinnNPEdwardsonJAIncePGBergeronCBurnsAMillerBLLovestoneSCollertonDJansenENBallardCde VosRAWilcockGKJellingerKAPerryRHConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopNeurology199647111311241:STN:280:DyaK2s%2FmsF2gtw%3D%3D8909416
WakabayashiKTakahashiHThe intermediolateral nucleus and Clarke’s column in Parkinson’s diseaseActa Neuropathol19979428728910.1007/s0040100507051:STN:280:DyaK2svjs1OhtA%3D%3D9292699
GiassonBIDudaJEFormanMSLeeVMTrojanowskiJQProminent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neuronsExp Neurol200117235436210.1006/exnr.2001.78051:CAS:528:DC%2BD3MXosFGhtr8%3D11716559
den Hartog JagerWABethlemJThe distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitansJ Neurol Neurosurg Psychiatry19602328329010.1136/jnnp.23.4.283
IkemuraMSaitoYSengokuRSakiyamaYHatsutaHKanemaruKSawabeMAraiTItoGIwatsuboTFukayamaMMurayamaSLewy body pathology involves cutaneous nervesJ Neuropathol Exp Neurol20086794595310.1097/NEN.0b013e318186de4818800013
KlosKJAhlskogJEJosephsKAApaydinHParisiJEBoeveBFDeLuciaMWDicksonDWAlpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individualsNeurology2006661100110210.1212/01.wnl.0000204179.88955.fa1:CAS:528:DC%2BD28XislWksr8%3D16606927
KordowerJHChuYHauserRAOlanowCWFreemanTBTransplanted dopaminergic neurons develop PD pathologic changes: a second case reportMov Disord2008232303230610.1002/mds.2236919006193
PinningtonLLMuhiddinKAEllisREPlayfordEDNon-invasive assessment of swallowing and respiration in Parkinson’s diseaseJ Neurol200024777377710.1007/s0041500700911:STN:280:DC%2BD3M7htlyjtQ%3D%3D11127532
BraakHGhebremedhinERubUBratzkeHDel TrediciKStages in the development of Parkinson’s disease-related pathologyCell Tissue Res200431812113410.1007/s00441-004-0956-915338272
SicaREHerskovitsEAguileraNPochGAn electrophysiological investigation of skeletal muscle in Parkinson’s diseaseJ Neurol Sci19731841142010.1016/0022-510X(73)90135-41:STN:280:DyaE3s7mtlGgsA%3D%3D4349282
ProulxMde CourvalFPWisemanMAPanissetMSalivary production in Parkinson’s diseaseMov Disord20052020420710.1002/mds.2018915389996
SiddiquiMFRastSLynnMJAuchusAPPfeifferRFAutonomic dysfunction in Parkinson’s disease: a comprehensive symptom surveyParkinsonism Relat Disord2002827728410.1016/S1353-8020(01)00052-91:STN:280:DC%2BD383pvFeltQ%3D%3D12039423
McKeithIGDicksonDWLoweJEmreMO’BrienJTFeldmanHCummingsJDudaJELippaCPerryEKAarslandDAraiHBallardCGBoeveBBurnDJCostaDDelSTDuboisBGalaskoDGauthierSGoetzCGGomez-TortosaEHallidayGHansenLAHardyJIwatsuboTKalariaRNKauferDKennyRAKorczynAKosakaKLeeVMLeesALitvanILondosELopezOLMinoshimaSMizunoYMolinaJAMukaetova-LadinskaEBPasquierFPerryRHSchulzJBTrojanowskiJQYamadaMDiagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumNeurology2005651863187210.1212/01.wnl.0000187889.17253.b11:STN:280:DC%2BD2Mnpt1GqsQ%3D%3D16237129
EdwardsLLQuigleyEMHarnedRKHofmanRPfeifferRFCharacterization of swallowing and defecation in Parkinson’s diseaseAm J Gastroenterol19948915251:STN:280:DyaK2c%2FpvFemsw%3D%3D8273792
BraitKFahnSSchwarzGASporadic and familial parkinsonism and motor neuron diseaseNeurology19732399010021:STN:280:DyaE3s3jvVeruw%3D%3D4737691
Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR (2007) Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord
BlochAProbstABissigHAdamsHTolnayMAlpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjectsNeuropathol Appl Neurobiol20063228429510.1111/j.1365-2990.2006.00727.x1:CAS:528:DC%2BD28XlvVyju78%3D16640647
BagheriHDamase-MichelCLapeyre-MestreMCismondoSO’ConnellDSenardJMRascolOMontastrucJLA study of salivary secretion in Parkinson’s diseaseClin Neuropharmacol1999222132151:STN:280:DyaK1MzntVygug%3D%3D10442250
KnowlesCHDeGRKapurRPBruderEFarrugiaGGeboesKGershonMDHutsonJLindbergGMartinJEMeier-RugeWAMillaPJSmithVVVandervindenJMVeressBWedelTGastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working GroupActa Neuropathol200911827130110.1007/s00401-009-0527-y19360428
BraakHBohlJRMullerCMRubUde VosRADel TrediciKStanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsideredMov Disord2006212042205110.1002/mds.2106517078043
JellingerKALewy body-related alpha-synucleinopathy in the aged human brainJ Neural Transm20041111219123510.1007/s00702-004-0138-71:CAS:528:DC%2BD2cXotFCrtbk%3D15480835
ZaccaiJBrayneCMcKeithIMatthewsFIncePGPatterns and stages of alpha-synucleinopathy: relevance in a population-based cohortNeurology2008701042104810.1212/01.wnl.0000306697.48738.b61:CAS:528:DC%2BD1cXjs1Kjtrk%3D18362284
HopkinsDABiegerDdeVenteJSteinbuschWMVagal efferent projections: viscerotopy, neurochemistry and effects of vagotomyProg Brain Res1996107799610.1016/S0079-6123(08)61859-21:STN:280:DyaK28zns1KnsA%3D%3D8782514
KupskyWJGrimesMMSweetingJBertschRCoteLJParkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cellsNeurology198737125312551:STN:280:DyaL2s3lvVyjug%3D%3D3037441
FumimuraYIkemuraMSaitoYSengokuRKanemaruKSawabeMAraiTItoGIwatsuboTFukayamaMMizusawaHMurayamaSAnalysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body diseaseJ Neuropathol Exp Neurol20076635436210.1097/nen.0b013e318051745417483692
AdlerCHHentzJGJoyceJNBeachTCavinessJNMotor impairment in normal aging, clinically possible Parkinson’s disease, and clinically probable Parkinson’s disease: longitudinal evaluation of a cohort of prospective brain donorsParkinsonism Relat Disord2002910311010.1016/S1353-8020(02)00012-312473400
LangstonJWThe Parkinson’s complex: parkinsonism is just the tip of the icebergAnn Neurol20065959159610.1002/ana.2083416566021
Minguez-CastellanosAChamorroCEEscamilla-SevillaFOrtega-MorenoARebolloACGomez-RioMConchaAMunozDGDo alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort studyNeurology2007682012201810.1212/01.wnl.0000264429.59379.d91:CAS:528:DC%2BD2sXlvVaqsbg%3D17548551
AbbottRDPetrovitchHWhiteLRMasakiKHTannerCMCurbJDGrandinettiABlanchettePLPo
CH Adler (664_CR4) 2005; 20
Y Fumimura (664_CR35) 2007; 66
N Hishikawa (664_CR39) 2000; 10
BI Giasson (664_CR37) 2001; 172
Y Miki (664_CR60) 2009; 24
NA Leopold (664_CR56) 1997; 12
M Proulx (664_CR68) 2005; 20
IG McKeith (664_CR58) 2005; 65
K Wakabayashi (664_CR79) 1997; 94
H Bagheri (664_CR6) 1999; 22
TG Beach (664_CR11) 2009; 117
J Christensen (664_CR25) 1984; 86
OR Tumilasci (664_CR76) 2006; 21
H Braak (664_CR20) 2003; 110
RE Sica (664_CR73) 1976; 16
JE Duda (664_CR31) 2002; 52
M Persson (664_CR65) 1992; 50
CH Hawkes (664_CR38) 2007; 33
N Hishikawa (664_CR40) 2003; 105
IG McKeith (664_CR59) 1996; 47
C Bouras (664_CR13) 1994; 4
DA Hopkins (664_CR42) 1996; 107
H Uchikado (664_CR77) 2006; 65
TG Beach (664_CR8) 2009; 117
LL Pinnington (664_CR67) 2000; 247
Y Saito (664_CR71) 2004; 63
J Zaccai (664_CR82) 2008; 70
DJ Gelb (664_CR36) 1999; 56
K Wakabayashi (664_CR81) 1988; 76
RF Pfeiffer (664_CR66) 2003; 2
KM Danzer (664_CR26) 2007; 27
CH Knowles (664_CR49) 2009; 118
JH Kordower (664_CR53) 2008; 23
SS Mirra (664_CR62) 1991; 41
Y Koike (664_CR50) 1997; 38
MF Siddiqui (664_CR74) 2002; 8
MC Bateson (664_CR7) 1973; 29
CL Hladik (664_CR41) 2003; 62
H Braak (664_CR15) 1991; 1
E Iseki (664_CR44) 1998; 258
JW Langston (664_CR55) 2006; 59
RE Sica (664_CR72) 1973; 18
JH Kordower (664_CR51) 2009; 34
A Minguez-Castellanos (664_CR61) 2007; 68
KJ Klos (664_CR48) 2006; 66
CH Adler (664_CR5) 2002; 9
H Fujiwara (664_CR34) 2002; 4
L Parkkinen (664_CR64) 2008; 115
A Bloch (664_CR12) 2006; 32
SS O’Sullivan (664_CR63) 2008; 79
K Brait (664_CR22) 1973; 23
H Braak (664_CR14) 2006; 21
M Ikemura (664_CR43) 2008; 67
H Braak (664_CR18) 2008; 70
P Desplats (664_CR30) 2009; 106
JN Caviness (664_CR24) 2000; 15
SJ Qualman (664_CR69) 1984; 87
664_CR3
H Braak (664_CR16) 1991; 82
664_CR1
H Braak (664_CR21) 2007; 113
KM Danzer (664_CR27) 2009; 111
RD Abbott (664_CR2) 2001; 57
H Fujishiro (664_CR33) 2008; 116
WJ Kupsky (664_CR54) 1987; 37
D Verbaan (664_CR78) 2007; 69
JN Caviness (664_CR23) 2002; 8
KA Jellinger (664_CR46) 2004; 111
K Del Tredici (664_CR28) 2002; 61
JH Kordower (664_CR52) 2008; 14
WA Hartog Jager den (664_CR29) 1960; 23
JY Li (664_CR57) 2008; 14
Y Saito (664_CR70) 2003; 62
LL Edwards (664_CR32) 1994; 89
TG Beach (664_CR10) 2008; 116
K Iwanaga (664_CR45) 1999; 52
K Wakabayashi (664_CR80) 1990; 79
H Braak (664_CR17) 2006; 396
H Braak (664_CR19) 2004; 318
H Kaufmann (664_CR47) 2004; 63
S Takeda (664_CR75) 1993; 86
TG Beach (664_CR9) 2008; 9
References_xml – reference: BourasCHofPRGiannakopoulosPMichelJPMorrisonJHRegional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospitalCereb Cortex1994413815010.1093/cercor/4.2.1381:STN:280:DyaK2czht1ygsQ%3D%3D8038565
– reference: QualmanSJHauptHMYangPHamiltonSREsophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson’s diseaseGastroenterology1984878488561:STN:280:DyaL2c3os1Kisw%3D%3D6088351
– reference: LangstonJWThe Parkinson’s complex: parkinsonism is just the tip of the icebergAnn Neurol20065959159610.1002/ana.2083416566021
– reference: BeachTGSueLIWalkerDGRoherAELueLVeddersLConnorDJSabbaghMNRogersJThe Sun Health Research Institute Brain Donation Program: description and experience, 1987–2007Cell Tissue Bank2008922924510.1007/s10561-008-9067-218347928
– reference: BraakHBohlJRMullerCMRubUde VosRADel TrediciKStanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson’s disease reconsideredMov Disord2006212042205110.1002/mds.2106517078043
– reference: BeachTGWhiteCLHamiltonRLDudaJEIwatsuboTDicksonDWRoncaroliFButtiniMHladikCLSueLINoorigianJVAdlerCHEvaluation of alpha-synuclein immunohistochemical methods used by invited expertsActa Neuropathol200811627728810.1007/s00401-008-0409-81:CAS:528:DC%2BD1cXpsVGjsr4%3D18626651
– reference: PerssonMOsterbergTGranerusAKKarlssonSInfluence of Parkinson’s disease on oral healthActa Odontol Scand199250374210.3109/000163592090127441:STN:280:DyaK383jtVCntg%3D%3D1348899
– reference: FujiwaraHHasegawaMDohmaeNKawashimaAMasliahEGoldbergMSShenJTakioKIwatsuboTAlpha-synuclein is phosphorylated in synucleinopathy lesionsNat Cell Biol2002416016410.1038/ncb8411:CAS:528:DC%2BD38XhsVKnur4%3D11813001
– reference: GiassonBIDudaJEFormanMSLeeVMTrojanowskiJQProminent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neuronsExp Neurol200117235436210.1006/exnr.2001.78051:CAS:528:DC%2BD3MXosFGhtr8%3D11716559
– reference: SaitoYRuberuNNSawabeMAraiTKazamaHHosoiTYamanouchiHMurayamaSLewy body-related alpha-synucleinopathy in agingJ Neuropathol Exp Neurol20046374274915290899
– reference: WakabayashiKTakahashiHThe intermediolateral nucleus and Clarke’s column in Parkinson’s diseaseActa Neuropathol19979428728910.1007/s0040100507051:STN:280:DyaK2svjs1OhtA%3D%3D9292699
– reference: SicaREHerskovitsEAguileraNPochGAn electrophysiological investigation of skeletal muscle in Parkinson’s diseaseJ Neurol Sci19731841142010.1016/0022-510X(73)90135-41:STN:280:DyaE3s7mtlGgsA%3D%3D4349282
– reference: KaufmannHNahmKPurohitDWolfeDAutonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodiesNeurology2004631093109515452307
– reference: AdlerCHNonmotor complications in Parkinson’s diseaseMov Disord200520Suppl 11S23S2910.1002/mds.2046015822106
– reference: HopkinsDABiegerDdeVenteJSteinbuschWMVagal efferent projections: viscerotopy, neurochemistry and effects of vagotomyProg Brain Res1996107799610.1016/S0079-6123(08)61859-21:STN:280:DyaK28zns1KnsA%3D%3D8782514
– reference: Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR (2007) Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord
– reference: HawkesCHDel TrediciKBraakHParkinson’s disease: a dual-hit hypothesisNeuropathol Appl Neurobiol20073359961410.1111/j.1365-2990.2007.00874.x1:STN:280:DC%2BD2snmsF2ltA%3D%3D17961138
– reference: McKeithIGDicksonDWLoweJEmreMO’BrienJTFeldmanHCummingsJDudaJELippaCPerryEKAarslandDAraiHBallardCGBoeveBBurnDJCostaDDelSTDuboisBGalaskoDGauthierSGoetzCGGomez-TortosaEHallidayGHansenLAHardyJIwatsuboTKalariaRNKauferDKennyRAKorczynAKosakaKLeeVMLeesALitvanILondosELopezOLMinoshimaSMizunoYMolinaJAMukaetova-LadinskaEBPasquierFPerryRHSchulzJBTrojanowskiJQYamadaMDiagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumNeurology2005651863187210.1212/01.wnl.0000187889.17253.b11:STN:280:DC%2BD2Mnpt1GqsQ%3D%3D16237129
– reference: BagheriHDamase-MichelCLapeyre-MestreMCismondoSO’ConnellDSenardJMRascolOMontastrucJLA study of salivary secretion in Parkinson’s diseaseClin Neuropharmacol1999222132151:STN:280:DyaK1MzntVygug%3D%3D10442250
– reference: BlochAProbstABissigHAdamsHTolnayMAlpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjectsNeuropathol Appl Neurobiol20063228429510.1111/j.1365-2990.2006.00727.x1:CAS:528:DC%2BD28XlvVyju78%3D16640647
– reference: SicaRESanzOPAn electrophysiological study of the functional changes in the spinal motoneurones in Parkinson’s diseaseElectromyogr Clin Neurophysiol1976164094171:STN:280:DyaE2s%2FptVyntA%3D%3D1009884
– reference: WakabayashiKTakahashiHOhamaEIkutaFParkinson’s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous systemActa Neuropathol19907958158310.1007/BF002942341:STN:280:DyaK3c3ps1ynsg%3D%3D1972853
– reference: Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease (1997) The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease Neurobiol Aging 18:S1–S2
– reference: KupskyWJGrimesMMSweetingJBertschRCoteLJParkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cellsNeurology198737125312551:STN:280:DyaL2s3lvVyjug%3D%3D3037441
– reference: ParkkinenLPirttilaTAlafuzoffIApplicability of current staging/categorization of alpha-synuclein pathology and their clinical relevanceActa Neuropathol200811539940710.1007/s00401-008-0346-618297293
– reference: DudaJEGiassonBIMabonMELeeVMTrojanowskiJQNovel antibodies to synuclein show abundant striatal pathology in Lewy body diseasesAnn Neurol20025220521010.1002/ana.102791:CAS:528:DC%2BD38XmsVOruro%3D12210791
– reference: HladikCLWhiteCLComparison of digestive enzyme and formic acid pretreatment for optimal immunohistochemical demonstration of alpha-synuclein-immunoreactive cerebral cortical Lewy neuritesJ Neuropathol Exp Neurol200362554
– reference: BraakHBraakEDemonstration of amyloid deposits and neurofibrillary changes in whole brain sectionsBrain Pathol1991121321610.1111/j.1750-3639.1991.tb00661.x1:STN:280:DyaK2c7it12msQ%3D%3D1669710
– reference: HishikawaNHashizumeYYoshidaMSobueGClinical and neuropathological correlates of Lewy body diseaseActa Neuropathol200310534135012624787
– reference: IsekiEMaruiWKosakaKAkiyamaHUedaKIwatsuboTDegenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body diseaseNeurosci Lett1998258818410.1016/S0304-3940(98)00856-81:CAS:528:DyaK1cXotVKitr8%3D9875532
– reference: SiddiquiMFRastSLynnMJAuchusAPPfeifferRFAutonomic dysfunction in Parkinson’s disease: a comprehensive symptom surveyParkinsonism Relat Disord2002827728410.1016/S1353-8020(01)00052-91:STN:280:DC%2BD383pvFeltQ%3D%3D12039423
– reference: ZaccaiJBrayneCMcKeithIMatthewsFIncePGPatterns and stages of alpha-synucleinopathy: relevance in a population-based cohortNeurology2008701042104810.1212/01.wnl.0000306697.48738.b61:CAS:528:DC%2BD1cXjs1Kjtrk%3D18362284
– reference: FumimuraYIkemuraMSaitoYSengokuRKanemaruKSawabeMAraiTItoGIwatsuboTFukayamaMMizusawaHMurayamaSAnalysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body diseaseJ Neuropathol Exp Neurol20076635436210.1097/nen.0b013e318051745417483692
– reference: KlosKJAhlskogJEJosephsKAApaydinHParisiJEBoeveBFDeLuciaMWDicksonDWAlpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individualsNeurology2006661100110210.1212/01.wnl.0000204179.88955.fa1:CAS:528:DC%2BD28XislWksr8%3D16606927
– reference: KoikeYTakahashiAAutonomic dysfunction in Parkinson’s diseaseEur Neurol199738Suppl 281210.1159/0001134709387797
– reference: O’SullivanSSHoltonJLMasseyLAWilliamsDRReveszTLeesAJParkinson’s disease with Onuf’s nucleus involvement mimicking multiple system atrophyJ Neurol Neurosurg Psychiatry20087923223410.1136/jnnp.2007.13331417951280
– reference: KnowlesCHDeGRKapurRPBruderEFarrugiaGGeboesKGershonMDHutsonJLindbergGMartinJEMeier-RugeWAMillaPJSmithVVVandervindenJMVeressBWedelTGastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working GroupActa Neuropathol200911827130110.1007/s00401-009-0527-y19360428
– reference: DanzerKMHaasenDKarowARMoussaudSHabeckMGieseAKretzschmarHHengererBKostkaMDifferent species of alpha-synuclein oligomers induce calcium influx and seedingJ Neurosci2007279220923210.1523/JNEUROSCI.2617-07.20071:CAS:528:DC%2BD2sXhtVSnsLfM17715357
– reference: den Hartog JagerWABethlemJThe distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitansJ Neurol Neurosurg Psychiatry19602328329010.1136/jnnp.23.4.283
– reference: BeachTGAdlerCHLueLSueLIBachalakuriJHenry-WatsonJSasseJBoyerSShirohiSBrooksREschbacherJWhiteCLIIIAkiyamaHCavinessJShillHAConnorDJSabbaghMNWalkerDGUnified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathol200911761363410.1007/s00401-009-0538-819399512
– reference: BeachTGWhiteCLIIIHladikCLSabbaghMNConnorDJShillHASueLISasseJBachalakuriJHenry-WatsonJAkiyamaHAdlerCHOlfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disordersActa Neuropathol200911716917410.1007/s00401-008-0450-71:CAS:528:DC%2BD1MXhtVCltLg%3D18982334
– reference: WakabayashiKTakahashiHTakedaSOhamaEIkutaFParkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexusesActa Neuropathol19887621722110.1007/BF006877671:STN:280:DyaL1M7gt1eqsA%3D%3D2850698
– reference: BraakHSastreMBohlJRde VosRADel TrediciKParkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neuronsActa Neuropathol200711342142910.1007/s00401-007-0193-x17294202
– reference: BraakHde VosRABohlJDel TrediciKGastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathologyNeurosci Lett2006396677210.1016/j.neulet.2005.11.0121:CAS:528:DC%2BD28XhsF2gurc%3D16330147
– reference: AbbottRDPetrovitchHWhiteLRMasakiKHTannerCMCurbJDGrandinettiABlanchettePLPopperJSRossGWFrequency of bowel movements and the future risk of Parkinson’s diseaseNeurology2001574564621:STN:280:DC%2BD3MvlslWruw%3D%3D11502913
– reference: KordowerJHBrundinPLewy body pathology in long-term fetal nigral transplants: is Parkinson’s disease transmitted from one neural system to another?Neuropsychopharmacology20093425410.1038/npp.2008.16119079079
– reference: CavinessJNSmithBEClarkeSJAdlerCHCaselliRJHentzJGManfredMSMuenterDMotor unit number estimates in idiopathic Parkinson’s diseaseParkinsonism Relat Disord2002816116410.1016/S1353-8020(01)00007-41:STN:280:DC%2BD383pvFenuw%3D%3D12039425
– reference: EdwardsLLQuigleyEMHarnedRKHofmanRPfeifferRFCharacterization of swallowing and defecation in Parkinson’s diseaseAm J Gastroenterol19948915251:STN:280:DyaK2c%2FpvFemsw%3D%3D8273792
– reference: KordowerJHChuYHauserRAOlanowCWFreemanTBTransplanted dopaminergic neurons develop PD pathologic changes: a second case reportMov Disord2008232303230610.1002/mds.2236919006193
– reference: LiJYEnglundEHoltonJLSouletDHagellPLeesAJLashleyTQuinnNPRehncronaSBjorklundAWidnerHReveszTLindvallOBrundinPLewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagationNat Med20081450150310.1038/nm17461:CAS:528:DC%2BD1cXlsFCmsrs%3D18391963
– reference: PfeifferRFGastrointestinal dysfunction in Parkinson’s diseaseLancet Neurol2003210711610.1016/S1474-4422(03)00307-712849267
– reference: VerbaanDMarinusJVisserMvan RoodenSMStiggelboutAMvan HiltenJJPatient-reported autonomic symptoms in Parkinson diseaseNeurology20076933334110.1212/01.wnl.0000266593.50534.e81:STN:280:DC%2BD2svislGrtg%3D%3D17646625
– reference: FujishiroHTsuboiYLinWLUchikadoHDicksonDWCo-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodiesActa Neuropathol2008116172410.1007/s00401-008-0383-11:CAS:528:DC%2BD1cXosVOjtb0%3D18446351
– reference: McKeithIGGalaskoDKosakaKPerryEKDicksonDWHansenLASalmonDPLoweJMirraSSByrneEJLennoxGQuinnNPEdwardsonJAIncePGBergeronCBurnsAMillerBLLovestoneSCollertonDJansenENBallardCde VosRAWilcockGKJellingerKAPerryRHConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopNeurology199647111311241:STN:280:DyaK2s%2FmsF2gtw%3D%3D8909416
– reference: AdlerCHHentzJGJoyceJNBeachTCavinessJNMotor impairment in normal aging, clinically possible Parkinson’s disease, and clinically probable Parkinson’s disease: longitudinal evaluation of a cohort of prospective brain donorsParkinsonism Relat Disord2002910311010.1016/S1353-8020(02)00012-312473400
– reference: CavinessJNSmithBEStevensJCAdlerCHCaselliRJReinersCAHentzJGMuenterMDMotor unit changes in sporadic idiopathic Parkinson’s diseaseMov Disord20001523824310.1002/1531-8257(200003)15:2<238::AID-MDS1006>3.0.CO;2-J1:STN:280:DC%2BD3c3hsVagtQ%3D%3D10752572
– reference: IkemuraMSaitoYSengokuRSakiyamaYHatsutaHKanemaruKSawabeMAraiTItoGIwatsuboTFukayamaMMurayamaSLewy body pathology involves cutaneous nervesJ Neuropathol Exp Neurol20086794595310.1097/NEN.0b013e318186de4818800013
– reference: TakedaSYamazakiKMiyakawaTAraiHParkinson’s disease with involvement of the parasympathetic gangliaActa Neuropathol19938639739810.1007/BF003694541:STN:280:DyaK2c%2FnvVOntQ%3D%3D8256591
– reference: MirraSSHeymanAMcKeelDSumiSMCrainBJBrownleeLMVogelFSHughesJPvan BelleGBergLThe Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s diseaseNeurology1991414794861:STN:280:DyaK3M7oslajsQ%3D%3D2011243
– reference: BraakHBraakENeuropathological stageing of Alzheimer-related changesActa Neuropathol (Berl)19918223925910.1007/BF003088091:STN:280:DyaK387gtFOiug%3D%3D
– reference: BraakHDel TrediciKInvited Article: nervous system pathology in sporadic Parkinson diseaseNeurology2008701916192510.1212/01.wnl.0000312279.49272.9f18474848
– reference: ChristensenJStilesMJRickGASutherlandJComparative anatomy of the myenteric plexus of the distal colon in eight mammalsGastroenterology1984867067131:STN:280:DyaL2c7jtlahsg%3D%3D6698371
– reference: DanzerKMKrebsSKWolffMBirkGHengererBSeeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathologyJ Neurochem200911119220310.1111/j.1471-4159.2009.06324.x1:CAS:528:DC%2BD1MXht1ertLbP19686384
– reference: Del TrediciKRubUde VosRABohlJRBraakHWhere does parkinson disease pathology begin in the brain?J Neuropathol Exp Neurol20026141342612030260
– reference: SaitoYKawashimaARuberuNNFujiwaraHKoyamaSSawabeMAraiTNaguraHYamanouchiHHasegawaMIwatsuboTMurayamaSAccumulation of phosphorylated alpha-synuclein in aging human brainJ Neuropathol Exp Neurol2003626446541:CAS:528:DC%2BD3sXlt1yqu78%3D12834109
– reference: HishikawaNHashizumeYHirayamaMImamuraKWashimiYKoikeYMabuchiCYoshidaMSobueGBrainstem-type Lewy body disease presenting with progressive autonomic failure and lethargyClin Auton Res20001013914310.1007/BF022780181:STN:280:DC%2BD3M%2FltVeqsA%3D%3D10954072
– reference: LeopoldNAKagelMCPharyngo-esophageal dysphagia in Parkinson’s diseaseDysphagia199712111810.1007/PL000095121:STN:280:DyaK2s7ltFykug%3D%3D8997827
– reference: MikiYMoriFWakabayashiKKurodaNOrimoSIncidental Lewy body disease restricted to the heart and stellate gangliaMov Disord2009242299230110.1002/mds.2277519795472
– reference: Minguez-CastellanosAChamorroCEEscamilla-SevillaFOrtega-MorenoARebolloACGomez-RioMConchaAMunozDGDo alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort studyNeurology2007682012201810.1212/01.wnl.0000264429.59379.d91:CAS:528:DC%2BD2sXlvVaqsbg%3D17548551
– reference: BatesonMCGibberdFBWilsonRSSalivary symptoms in Parkinson diseaseArch Neurol1973292742751:STN:280:DyaE3s3ks1Siug%3D%3D4728188
– reference: ProulxMde CourvalFPWisemanMAPanissetMSalivary production in Parkinson’s diseaseMov Disord20052020420710.1002/mds.2018915389996
– reference: BraitKFahnSSchwarzGASporadic and familial parkinsonism and motor neuron diseaseNeurology19732399010021:STN:280:DyaE3s3jvVeruw%3D%3D4737691
– reference: KordowerJHChuYHauserRAFreemanTBOlanowCWLewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s diseaseNat Med20081450450610.1038/nm17471:CAS:528:DC%2BD1cXlsFCmsrg%3D18391962
– reference: DesplatsPLeeHJBaeEJPatrickCRockensteinECrewsLSpencerBMasliahELeeSJInclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synucleinProc Natl Acad Sci USA2009106130101301510.1073/pnas.09036911061:CAS:528:DC%2BD1MXhtVKru7%2FM19651612
– reference: BraakHGhebremedhinERubUBratzkeHDel TrediciKStages in the development of Parkinson’s disease-related pathologyCell Tissue Res200431812113410.1007/s00441-004-0956-915338272
– reference: GelbDJOliverEGilmanSDiagnostic criteria for Parkinson diseaseArch Neurol199956333910.1001/archneur.56.1.331:STN:280:DyaK1M7itVKgtg%3D%3D9923759
– reference: IwanagaKWakabayashiKYoshimotoMTomitaISatohHTakashimaHSatohASetoMTsujihataMTakahashiHLewy body-type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseasesNeurology199952126912711:STN:280:DyaK1M3ivFGluw%3D%3D10214756
– reference: JellingerKALewy body-related alpha-synucleinopathy in the aged human brainJ Neural Transm20041111219123510.1007/s00702-004-0138-71:CAS:528:DC%2BD2cXotFCrtbk%3D15480835
– reference: TumilasciORCersosimoMGBelforteJEMicheliFEBenarrochEEPazoJHQuantitative study of salivary secretion in Parkinson’s diseaseMov Disord20062166066710.1002/mds.2078416419045
– reference: BraakHRubUGaiWPDel TrediciKIdiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogenJ Neural Transm200311051753610.1007/s00702-002-0808-21:STN:280:DC%2BD3s3gt1GltQ%3D%3D12721813
– reference: UchikadoHLinWLDeLuciaMWDicksonDWAlzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathyJ Neuropathol Exp Neurol20066568569710.1097/01.jnen.0000225908.90052.071:CAS:528:DC%2BD28XotFeiu7c%3D16825955
– reference: PinningtonLLMuhiddinKAEllisREPlayfordEDNon-invasive assessment of swallowing and respiration in Parkinson’s diseaseJ Neurol200024777377710.1007/s0041500700911:STN:280:DC%2BD3M7htlyjtQ%3D%3D11127532
– volume: 82
  start-page: 239
  year: 1991
  ident: 664_CR16
  publication-title: Acta Neuropathol (Berl)
  doi: 10.1007/BF00308809
– volume: 15
  start-page: 238
  year: 2000
  ident: 664_CR24
  publication-title: Mov Disord
  doi: 10.1002/1531-8257(200003)15:2<238::AID-MDS1006>3.0.CO;2-J
– volume: 66
  start-page: 1100
  year: 2006
  ident: 664_CR48
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000204179.88955.fa
– volume: 105
  start-page: 341
  year: 2003
  ident: 664_CR40
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-002-0651-4
– volume: 29
  start-page: 274
  year: 1973
  ident: 664_CR7
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1973.00490280086013
– volume: 57
  start-page: 456
  year: 2001
  ident: 664_CR2
  publication-title: Neurology
  doi: 10.1212/WNL.57.3.456
– volume: 115
  start-page: 399
  year: 2008
  ident: 664_CR64
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0346-6
– volume: 396
  start-page: 67
  year: 2006
  ident: 664_CR17
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2005.11.012
– volume: 118
  start-page: 271
  year: 2009
  ident: 664_CR49
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-009-0527-y
– volume: 21
  start-page: 2042
  year: 2006
  ident: 664_CR14
  publication-title: Mov Disord
  doi: 10.1002/mds.21065
– volume: 8
  start-page: 277
  year: 2002
  ident: 664_CR74
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/S1353-8020(01)00052-9
– volume: 4
  start-page: 138
  year: 1994
  ident: 664_CR13
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/4.2.138
– volume: 33
  start-page: 599
  year: 2007
  ident: 664_CR38
  publication-title: Neuropathol Appl Neurobiol
  doi: 10.1111/j.1365-2990.2007.00874.x
– volume: 10
  start-page: 139
  year: 2000
  ident: 664_CR39
  publication-title: Clin Auton Res
  doi: 10.1007/BF02278018
– volume: 21
  start-page: 660
  year: 2006
  ident: 664_CR76
  publication-title: Mov Disord
  doi: 10.1002/mds.20784
– volume: 2
  start-page: 107
  year: 2003
  ident: 664_CR66
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(03)00307-7
– volume: 23
  start-page: 283
  year: 1960
  ident: 664_CR29
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.23.4.283
– volume: 70
  start-page: 1042
  year: 2008
  ident: 664_CR82
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000306697.48738.b6
– volume: 37
  start-page: 1253
  year: 1987
  ident: 664_CR54
  publication-title: Neurology
  doi: 10.1212/WNL.37.7.1253
– volume: 69
  start-page: 333
  year: 2007
  ident: 664_CR78
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000266593.50534.e8
– volume: 9
  start-page: 103
  year: 2002
  ident: 664_CR5
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/S1353-8020(02)00012-3
– volume: 14
  start-page: 504
  year: 2008
  ident: 664_CR52
  publication-title: Nat Med
  doi: 10.1038/nm1747
– volume: 172
  start-page: 354
  year: 2001
  ident: 664_CR37
  publication-title: Exp Neurol
  doi: 10.1006/exnr.2001.7805
– volume: 247
  start-page: 773
  year: 2000
  ident: 664_CR67
  publication-title: J Neurol
  doi: 10.1007/s004150070091
– volume: 79
  start-page: 581
  year: 1990
  ident: 664_CR80
  publication-title: Acta Neuropathol
  doi: 10.1007/BF00294234
– volume: 89
  start-page: 15
  year: 1994
  ident: 664_CR32
  publication-title: Am J Gastroenterol
– volume: 23
  start-page: 2303
  year: 2008
  ident: 664_CR53
  publication-title: Mov Disord
  doi: 10.1002/mds.22369
– volume: 63
  start-page: 742
  year: 2004
  ident: 664_CR71
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1093/jnen/63.7.742
– volume: 8
  start-page: 161
  year: 2002
  ident: 664_CR23
  publication-title: Parkinsonism Relat Disord
  doi: 10.1016/S1353-8020(01)00007-4
– volume: 47
  start-page: 1113
  year: 1996
  ident: 664_CR59
  publication-title: Neurology
  doi: 10.1212/WNL.47.5.1113
– volume: 318
  start-page: 121
  year: 2004
  ident: 664_CR19
  publication-title: Cell Tissue Res
  doi: 10.1007/s00441-004-0956-9
– volume: 66
  start-page: 354
  year: 2007
  ident: 664_CR35
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/nen.0b013e3180517454
– volume: 111
  start-page: 192
  year: 2009
  ident: 664_CR27
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2009.06324.x
– volume: 23
  start-page: 990
  year: 1973
  ident: 664_CR22
  publication-title: Neurology
  doi: 10.1212/WNL.23.9.990
– volume: 12
  start-page: 11
  year: 1997
  ident: 664_CR56
  publication-title: Dysphagia
  doi: 10.1007/PL00009512
– volume: 50
  start-page: 37
  year: 1992
  ident: 664_CR65
  publication-title: Acta Odontol Scand
  doi: 10.3109/00016359209012744
– ident: 664_CR3
  doi: 10.1002/mds.21560
– volume: 86
  start-page: 706
  year: 1984
  ident: 664_CR25
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(84)80120-1
– volume: 52
  start-page: 1269
  year: 1999
  ident: 664_CR45
  publication-title: Neurology
  doi: 10.1212/WNL.52.6.1269
– volume: 62
  start-page: 554
  year: 2003
  ident: 664_CR41
  publication-title: J Neuropathol Exp Neurol
– volume: 111
  start-page: 1219
  year: 2004
  ident: 664_CR46
  publication-title: J Neural Transm
  doi: 10.1007/s00702-004-0138-7
– volume: 79
  start-page: 232
  year: 2008
  ident: 664_CR63
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2007.133314
– volume: 116
  start-page: 277
  year: 2008
  ident: 664_CR10
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0409-8
– volume: 1
  start-page: 213
  year: 1991
  ident: 664_CR15
  publication-title: Brain Pathol
  doi: 10.1111/j.1750-3639.1991.tb00661.x
– volume: 67
  start-page: 945
  year: 2008
  ident: 664_CR43
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/NEN.0b013e318186de48
– volume: 34
  start-page: 254
  year: 2009
  ident: 664_CR51
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2008.161
– volume: 86
  start-page: 397
  year: 1993
  ident: 664_CR75
  publication-title: Acta Neuropathol
  doi: 10.1007/BF00369454
– volume: 87
  start-page: 848
  year: 1984
  ident: 664_CR69
  publication-title: Gastroenterology
  doi: 10.1016/0016-5085(84)90079-9
– volume: 4
  start-page: 160
  year: 2002
  ident: 664_CR34
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb841
– volume: 62
  start-page: 644
  year: 2003
  ident: 664_CR70
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1093/jnen/62.6.644
– volume: 70
  start-page: 1916
  year: 2008
  ident: 664_CR18
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000312279.49272.9f
– volume: 116
  start-page: 17
  year: 2008
  ident: 664_CR33
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0383-1
– volume: 56
  start-page: 33
  year: 1999
  ident: 664_CR36
  publication-title: Arch Neurol
  doi: 10.1001/archneur.56.1.33
– ident: 664_CR1
– volume: 94
  start-page: 287
  year: 1997
  ident: 664_CR79
  publication-title: Acta Neuropathol
  doi: 10.1007/s004010050705
– volume: 61
  start-page: 413
  year: 2002
  ident: 664_CR28
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1093/jnen/61.5.413
– volume: 117
  start-page: 613
  year: 2009
  ident: 664_CR8
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-009-0538-8
– volume: 117
  start-page: 169
  year: 2009
  ident: 664_CR11
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0450-7
– volume: 65
  start-page: 685
  year: 2006
  ident: 664_CR77
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/01.jnen.0000225908.90052.07
– volume: 9
  start-page: 229
  year: 2008
  ident: 664_CR9
  publication-title: Cell Tissue Bank
  doi: 10.1007/s10561-008-9067-2
– volume: 41
  start-page: 479
  year: 1991
  ident: 664_CR62
  publication-title: Neurology
  doi: 10.1212/WNL.41.4.479
– volume: 258
  start-page: 81
  year: 1998
  ident: 664_CR44
  publication-title: Neurosci Lett
  doi: 10.1016/S0304-3940(98)00856-8
– volume: 63
  start-page: 1093
  year: 2004
  ident: 664_CR47
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000138500.73671.DC
– volume: 32
  start-page: 284
  year: 2006
  ident: 664_CR12
  publication-title: Neuropathol Appl Neurobiol
  doi: 10.1111/j.1365-2990.2006.00727.x
– volume: 65
  start-page: 1863
  year: 2005
  ident: 664_CR58
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000187889.17253.b1
– volume: 59
  start-page: 591
  year: 2006
  ident: 664_CR55
  publication-title: Ann Neurol
  doi: 10.1002/ana.20834
– volume: 113
  start-page: 421
  year: 2007
  ident: 664_CR21
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-007-0193-x
– volume: 20
  start-page: 204
  year: 2005
  ident: 664_CR68
  publication-title: Mov Disord
  doi: 10.1002/mds.20189
– volume: 24
  start-page: 2299
  year: 2009
  ident: 664_CR60
  publication-title: Mov Disord
  doi: 10.1002/mds.22775
– volume: 20
  start-page: S23
  issue: Suppl 11
  year: 2005
  ident: 664_CR4
  publication-title: Mov Disord
  doi: 10.1002/mds.20460
– volume: 68
  start-page: 2012
  year: 2007
  ident: 664_CR61
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000264429.59379.d9
– volume: 16
  start-page: 409
  year: 1976
  ident: 664_CR73
  publication-title: Electromyogr Clin Neurophysiol
– volume: 38
  start-page: 8
  issue: Suppl 2
  year: 1997
  ident: 664_CR50
  publication-title: Eur Neurol
  doi: 10.1159/000113470
– volume: 18
  start-page: 411
  year: 1973
  ident: 664_CR72
  publication-title: J Neurol Sci
  doi: 10.1016/0022-510X(73)90135-4
– volume: 76
  start-page: 217
  year: 1988
  ident: 664_CR81
  publication-title: Acta Neuropathol
  doi: 10.1007/BF00687767
– volume: 106
  start-page: 13010
  year: 2009
  ident: 664_CR30
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0903691106
– volume: 110
  start-page: 517
  year: 2003
  ident: 664_CR20
  publication-title: J Neural Transm
  doi: 10.1007/s00702-002-0808-2
– volume: 22
  start-page: 213
  year: 1999
  ident: 664_CR6
  publication-title: Clin Neuropharmacol
– volume: 14
  start-page: 501
  year: 2008
  ident: 664_CR57
  publication-title: Nat Med
  doi: 10.1038/nm1746
– volume: 52
  start-page: 205
  year: 2002
  ident: 664_CR31
  publication-title: Ann Neurol
  doi: 10.1002/ana.10279
– volume: 27
  start-page: 9220
  year: 2007
  ident: 664_CR26
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2617-07.2007
– volume: 107
  start-page: 79
  year: 1996
  ident: 664_CR42
  publication-title: Prog Brain Res
  doi: 10.1016/S0079-6123(08)61859-2
SSID ssj0012745
Score 2.532852
Snippet A sensitive immunohistochemical method for phosphorylated α-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites in...
A sensitive immunohistochemical method for phosphorylated alpha-synuclein was used to stain sets of sections of spinal cord and tissue from 41 different sites...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 689
SubjectTerms Aged
Aged, 80 and over
alpha-Synuclein - metabolism
Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Brain - metabolism
Brain - pathology
Female
Ganglia, Sympathetic - metabolism
Ganglia, Sympathetic - pathology
Gastrointestinal Tract - metabolism
Gastrointestinal Tract - pathology
Humans
Immunohistochemistry
Lewy Body Disease - metabolism
Lewy Body Disease - pathology
Male
Medicine
Medicine & Public Health
Neurosciences
Original Paper
Parkinson Disease - metabolism
Parkinson Disease - pathology
Pathology
Peripheral Nervous System - metabolism
Peripheral Nervous System - pathology
Phosphorylation
Spinal Cord - metabolism
Spinal Cord - pathology
Title Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
URI https://link.springer.com/article/10.1007/s00401-010-0664-3
https://www.ncbi.nlm.nih.gov/pubmed/20306269
https://www.proquest.com/docview/733405171
https://pubmed.ncbi.nlm.nih.gov/PMC2866090
Volume 119
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3LatwwFL00CZRuSt91H4MWXbUIZEmWrOW0TBrSNpTSgenKSLJNQoMd4hnKfFZ_pN_UK_kB06SBLIzBvhLGR4_70rkAb0yaOdyHKqq9Y1QKndE8456K2vhc5VbKOmZbnKijpTxeZavhHHc3ZruPIcm4Uk-H3cJ4C6ZvKJSiJBV7cJAF0x0H8ZLPp9ABmll92QIUVjhcx1DmdV3sbkZXNMyriZL_REvjJnT4AO4P2iOZ93A_hDtV8wjufhni44_hZzxPS2OpJlIGTtyhnBVpa3Jx2nZ4XW7PUb8syZ_ftNs2gc74rCGRdjhUJ45edoJPuo0LLpqOBE8t-Vz92hLXltvQa6Tr7J7A8nDx_cMRHcopUC9MvqZ15aVTlrlU2hrNCleyzEmtvHc649YIh3hyZ41x3iBEjDuZpqbU2JCV1omnsN-0TfUcSG04ZxaVL-ut9LWwXOBaYV3gPa1VaRNg438t_MA1HkpenBcTS3KEokAoigBFIRJ4OzW56Ik2bhImI1gFTocQ47BN1W66QgshA-1YmsCzHrupNx7MI65MAnoH1UkgMG3vvmnOTiPjNs-VYoYl8G7Evximevf_j3xxK-mXcK9PTAgOnlewv77cVK9R31m7GezplZ7Bwfzjj08LvL9fnHz9Nouj_i8eN_77
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3LatwwFL00KTTdlDZtUvepRVYtAlmSZWsZSsO0nWSVgeyEJNskJNghnqHMZ_VH8k3RlR8wTVPIwhv7ShgdPe5L5wIc6DRz4RyqaO4do1LkGS0y7qmotS9UYaWsY7bFiZot5M-z7Gy4x92N2e5jSDLu1NNlN5xvaPpioRQlqdiCp0EXKDCPa8EPp9BBMLP6sgVBWIXpOoYy_9XF5mF0T8O8nyj5V7Q0HkJHL-HFoD2Swx7uV_Ckanbh2fEQH38Nl_E-LY2lmkiJnLhDOSvS1uT6vO3Cc7O-CvplSW7_0G7dIJ3xRUMi7TBWJ45edhLedCuHLpqOoKeWzKvfa-Laco29RrrO7g0sjr6ffpvRoZwC9UIXS1pXXjplmUulrYNZ4UqWOZkr712ecauFC3hyZ7V2XgeIGHcyTXWZh4astE7swXbTNtVbILXmnNmgfFlvpa-F5SLsFdYh72mtSpsAG8fV-IFrHEteXJmJJTlCYQIUBqEwIoEvU5Prnmjjf8JkBMuE5YAxDttU7aozuRASacfSBPZ77KbeOJpHXOkE8g1UJwFk2t780lycR8ZtXijFNEvg64i_GZZ69_BPvnuU9GfYmZ0ez838x8mv9_C8T1JAZ88H2F7erKqPQfdZuk9xrt8BYNH92Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkSouiDfh6QMnkFXHdpz4WAGrAqXiwEq9WbYTq1WrZNXsCu3P4o_wm_A4D2kpIHHIJRlbUb5xPC9_A_Ba54WL-1BDS-8YlaIsaFVwT0XQvlKVlTKkaosTdbSUn06L07HPaT9Vu08pyeFMA7I0teuDVR0O5oNvqHvoBmPTFCWpuAm34t84R7Ve8sM5jRBdrqGFQRRWUXWntOafptjdmK5Zm9eLJn_LnKYNaXEX7oyWJDkcoL8HN5r2Pux_GXPlD-Aina2lqW0TqZEfd2xtRbpAVmddH6-r7WW0NWvy8wftty1SG5-3JFEQY6fiFHEn8U6_cRiu6QlGbclx831LXFdvcdZE3dk_hOXiw7d3R3RsrUC90NWahsZLpyxzubQhuhiuZoWTpfLelQW3WriILXdWa-d1hItxJ_Nc12UcyGrrxCPYa7u2eQIkaM6ZjYaY9Vb6ICwX8b9hHXKgBlXbDNj0XY0fecex_cWlmRmTExQmQmEQCiMyeDMPWQ2kG_8SJhNYJi4NzHfYtuk2vSmFkEhBlmfweMBuno2jq8SVzqDcQXUWQNbt3Sft-Vli3-aVUkyzDN5O-Jtx2fd_f8mn_yX9Cva_vl-Y448nn5_B7aFeAeM-z2FvfbVpXkQzaO1eJlX_BaEUAiQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multi-organ+distribution+of+phosphorylated+%CE%B1-synuclein+histopathology+in+subjects+with+Lewy+body+disorders&rft.jtitle=Acta+neuropathologica&rft.au=Beach%2C+Thomas+G.&rft.au=Adler%2C+Charles+H.&rft.au=Sue%2C+Lucia+I.&rft.au=Vedders%2C+Linda&rft.date=2010-06-01&rft.issn=0001-6322&rft.eissn=1432-0533&rft.volume=119&rft.issue=6&rft.spage=689&rft.epage=702&rft_id=info:doi/10.1007%2Fs00401-010-0664-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00401_010_0664_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-6322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-6322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-6322&client=summon